BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34653800)

  • 1. Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer.
    Gou Q; Zhang CZ; Sun ZH; Wu LG; Chen Y; Mo ZQ; Mai QC; He J; Zhou ZX; Shi F; Cui W; Zou W; Lv L; Zhuang WH; Xu RD; Li WK; Zhang J; Du HW; Xiang JX; Wang HZ; Hou T; Li ST; Li Y; Chen XM; Zhou ZJ
    ESMO Open; 2021 Dec; 6(6):100275. PubMed ID: 34653800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile cell‑free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer.
    Shen N; Zhang D; Yin L; Qiu Y; Liu J; Yu W; Fu X; Zhu B; Xu X; Duan A; Chen Z; Wang X; Cao X; Zhao T; Zhou Z; Yu L; Qin H; Fang Z; Li JY; Liu Y; Xiong L; Yuan B; Li F; Zhang Y
    Oncol Rep; 2019 Aug; 42(2):549-560. PubMed ID: 31173267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer.
    Berchuck JE; Facchinetti F; DiToro DF; Baiev I; Majeed U; Reyes S; Chen C; Zhang K; Sharman R; Uson Junior PLS; Maurer J; Shroff RT; Pritchard CC; Wu MJ; Catenacci DVT; Javle M; Friboulet L; Hollebecque A; Bardeesy N; Zhu AX; Lennerz JK; Tan B; Borad M; Parikh AR; Kiedrowski LA; Kelley RK; Mody K; Juric D; Goyal L
    Ann Oncol; 2022 Dec; 33(12):1269-1283. PubMed ID: 36089135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile is a reliable and valuable source to study cfDNA in biliary tract cancers.
    Li Z; Liu Y; Fu J; Mugaanyi J; Yan J; Lu C; Huang J
    Front Oncol; 2022; 12():961939. PubMed ID: 36091112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the genomic profiles of cell-free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC.
    Wu Z; Yang Z; Li CS; Zhao W; Liang ZX; Dai Y; Zhu Q; Miao KL; Cui DH; Chen LA
    Cancer Med; 2019 Mar; 8(3):910-919. PubMed ID: 30767431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Evaluation and Application of a Novel Method to Isolate Cell-Free DNA Derived From Bile of Biliary Tract Cancer Patients.
    Shen N; Zhu B; Zhang W; Nian B; Xu X; Yu L; Ruan X; Chen S; Liu Y; Cao X; Shi X; Li Z; Huang X; Wang X; Chen C; Xiong L; Zhang D; Fu X; Zhang Y
    Front Oncol; 2022; 12():891917. PubMed ID: 35600407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency.
    Bustamante Alvarez JG; Janse S; Owen DH; Kiourtsis S; Bertino EM; He K; Carbone DP; Otterson GA
    Clin Lung Cancer; 2021 Jul; 22(4):e519-e527. PubMed ID: 33414052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing.
    Chen E; Cario CL; Leong L; Lopez K; Márquez CP; Li PS; Oropeza E; Tenggara I; Cowan J; Simko JP; Kageyama R; Wells DK; Chan JM; Friedlander T; Aggarwal R; Paris PL; Feng F; Carroll PR; Witte JS
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing.
    Kang JK; Heo S; Kim HP; Song SH; Yun H; Han SW; Kang GH; Bang D; Kim TY
    PLoS One; 2020; 15(5):e0232754. PubMed ID: 32379795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectives.
    Arrichiello G; Nacca V; Paragliola F; Giunta EF
    Explor Target Antitumor Ther; 2022; 3(3):362-374. PubMed ID: 36045913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid Biopsy from Bile-Circulating Tumor DNA in Patients with Biliary Tract Cancer.
    Han JY; Ahn KS; Kim TS; Kim YH; Cho KB; Shin DW; Baek WK; Suh SI; Jang BC; Kang KJ
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA.
    Yuan Z; Wang X; Geng X; Li Y; Tan F; Xue Q; Gao S; He J
    Cancer Genet; 2021 Nov; 258-259():93-100. PubMed ID: 34688997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Sequences of Circulating Tumor DNA of Cholangiocarcinomas and Its Applications and Limitations in Clinical Practice.
    Kim KH; Yi HS; Lee H; Bae GE; Yeo MK
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets.
    Tu HY; Li YS; Bai XY; Sun YL; Zheng MY; Ke EE; Liao RQ; Jiang BY; Lin JX; Huang J; Xu BF; Yang JJ; Zhang XC; Zhou Q; Wang BC; Chen HJ; Tong X; Yu R; Wu X; Zhu D; Wu YL
    Clin Lung Cancer; 2022 Mar; 23(2):135-142. PubMed ID: 34645582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy.
    Li YS; Jiang BY; Yang JJ; Zhang XC; Zhang Z; Ye JY; Zhong WZ; Tu HY; Chen HJ; Wang Z; Xu CR; Wang BC; Du HJ; Chuai S; Han-Zhang H; Su J; Zhou Q; Yang XN; Guo WB; Yan HH; Liu YH; Yan LX; Huang B; Zheng MM; Wu YL
    Ann Oncol; 2018 Apr; 29(4):945-952. PubMed ID: 29346604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
    Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
    Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring.
    Qi F; Cao Z; Chen B; Chai Y; Lin J; Ye J; Wei Y; Liu H; Han-Zhang H; Mao X; Feng X; Dong M
    Blood Adv; 2021 Jun; 5(11):2505-2514. PubMed ID: 34047776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole exome sequencing of cell-free DNA - A systematic review and Bayesian individual patient data meta-analysis.
    Bos MK; Angus L; Nasserinejad K; Jager A; Jansen MPHM; Martens JWM; Sleijfer S
    Cancer Treat Rev; 2020 Feb; 83():101951. PubMed ID: 31874446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing.
    Csoma SL; Bedekovics J; Veres G; Árokszállási A; András C; Méhes G; Mokánszki A
    Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA.
    Kim ST; Lira M; Deng S; Lee S; Park YS; Lim HY; Kang WK; Mao M; Heo JS; Kwon W; Jang KT; Lee J; Park JO
    Oncotarget; 2015 Nov; 6(37):40026-35. PubMed ID: 26498688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.